Moderna Inc. stock falls on Tuesday, underperforming the market



[ad_1]

Shares of Moderna Inc. MRNA,
-7.68%
lost 7.68% to $ 141.01 on Tuesday, in what turned out to be a favorable trading session for the stock market, with the NASDAQ Composite Index COMP,
+ 1.28%
up 1.28% to 12,355.11 and the Dow Jones Industrial Average DJIA,
+ 0.62%
up 0.63% to 29,823.92. The fall in the stock broke a three-day streak. Moderna Inc. closed $ 12.86 lower than its 52-week high ($ 153.87), which the company reached on November 30.

The stock underperformed some of its rivals on Tuesday, such as AbbVie Inc. ABBV,
-0.51%
fell 0.52% to $ 104.04, Amgen Inc. AMGN,
+ 1.36%
increased 1.37% to $ 225.08, and AstraZeneca PLC ADR AZN,
+ 0.07%
rose 0.08% to $ 52.98. Trade volume (124.1 M) eclipsed its 50-day average volume of 12.6 Mio.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

[ad_2]

Source link